With the Allergan acquisition, we are bringing together over 30 brands and leadership positions to expand and diversify our product portfolio.  This allows us to have immediate scale and profitability to advance our innovative science pipeline that brings patients groundbreaking medicines across a wide spectrum of therapeutic need/critical therapeutic areas.

We continue to build a sustainable company for the long term that provides profitable growth for shareholders, financial flexibility to invest and expand our reach to help address the needs of people and communities around the world. 

The Facts: AbbVie

Today, more than ever, we are well-positioned with resources and focus to deliver on our commitments and turn possibilities into reality for more patients. 

Resources

AbbVie is currently reviewing all content on Allergan.com.  As we work through the successful integration of Allergan and consolidation of content, information will be updated.